John Milligan
Chairman presso PACIFIC BIOSCIENCES OF CALIFORNIA, INC.
Patrimonio netto: 4 M $ in data 31/03/2024
Profilo
Il dottor John F. Milligan è presidente esecutivo della 4D Molecular Therapeutics, Inc. e presidente della Pacific Biosciences of California, Inc. Fa parte del consiglio di amministrazione della Biotechnology Innovation Organization e della Ohio Wesleyan University. Il Dr. Milligan è stato precedentemente impiegato come Presidente di Pharmasset, Inc., Direttore-Project Management di Hoffmann-La Roche, Inc. e Presidente, Amministratore Delegato e Direttore di Gilead Sciences, Inc. Si è laureato alla Ohio Wesleyan University e ha conseguito il dottorato alla University of Illinois.
Partecipazioni note in società pubbliche
| Società | Data | Numero di azioni | Valorizzazione | Data di valutazione |
|---|---|---|---|---|
| 23/05/2023 | 100 000 ( 0.20% ) | 3 M $ | 31/03/2024 | |
| 24/05/2023 | 110 000 ( 0.04% ) | 412 500 $ | 31/03/2024 |
Posizioni attive di John Milligan
| Società | Posizione | Inizio |
|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Chairman | 14/09/2020 |
| 4D MOLECULAR THERAPEUTICS, INC. | Chairman | 01/08/2020 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 22/07/2011 |
| Ohio Wesleyan University | Chairman | - |
Precedenti posizioni note di John Milligan
| Società | Posizione | Fine |
|---|---|---|
| GILEAD SCIENCES, INC. | Chief Executive Officer | 31/12/2018 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | President | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Formazione di John Milligan
| Ohio Wesleyan University | Undergraduate Degree |
| University of Illinois | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Health Technology |
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| Aziende private | 3 |
|---|---|
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
- Borsa valori
- Insiders
- John Milligan
